COC(=O)[C@@H](NC1(c2ccccc2)c2ccccc2-c2ccccc21)[C@H](OC(=O)[C@H]1CCCN1S(=O)(=O)c1ccccc1)C(=O)OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?